445 related articles for article (PubMed ID: 24515813)
1. Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients.
Ortiz-Sanjuán F; Blanco R; Calvo-Rio V; Narvaez J; Rubio Romero E; Olivé A; Castañeda S; Gallego Flores A; Hernández MV; Mata C; Ros Vilamajo I; Sifuentes Giraldo WA; Caracuel MA; Freire M; Gómez Arango C; Llobet J; Manrique Arija S; Marras C; Moll-Tuduri C; Plasencia-Rodriguez C; Roselló R; Urruticoechea A; Velloso-Feijoo ML; Del Blanco J; González-Vela MC; Rueda-Gotor J; Pina T; Loricera J; González-Gay MA
Arthritis Rheumatol; 2014 Jun; 66(6):1659-65. PubMed ID: 24515813
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases.
Song ST; Kim JJ; Lee S; Kim HA; Lee EY; Shin KC; Lee JH; Lee KH; Choi ST; Cha HS; Yoo DH
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S64-S71. PubMed ID: 27462914
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab in adult-onset Still's disease: the Israeli experience.
Elkayam O; Jiries N; Dranitzki Z; Kivity S; Lidar M; Levy O; Ablin J; Abu-Shakra M; Savargyl-Maman H; Padova H; Caspi D; Rosner I
J Rheumatol; 2014 Feb; 41(2):244-7. PubMed ID: 24429168
[TBL] [Abstract][Full Text] [Related]
4. The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study.
Nishina N; Kaneko Y; Kameda H; Takeuchi T
Mod Rheumatol; 2015 May; 25(3):401-4. PubMed ID: 25401229
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still's disease: A meta-analysis.
Ma Y; Wu M; Zhang X; Xia Q; Yang J; Xu S; Pan F
Mod Rheumatol; 2018 Sep; 28(5):849-857. PubMed ID: 29251027
[TBL] [Abstract][Full Text] [Related]
6. Tocilizumab for the treatment of adult-onset Still's disease: results from a case series.
Cipriani P; Ruscitti P; Carubbi F; Pantano I; Liakouli V; Berardicurti O; Giacomelli R
Clin Rheumatol; 2014 Jan; 33(1):49-55. PubMed ID: 24005839
[TBL] [Abstract][Full Text] [Related]
7. Two cases of adult-onset Still's disease treated with tocilizumab that achieved tocilizumab-free remission.
Kobayashi D; Ito S; Murasawa A; Narita I; Nakazono K
Intern Med; 2015; 54(20):2675-9. PubMed ID: 26466710
[TBL] [Abstract][Full Text] [Related]
8. Tocilizumab in refractory adult Still's disease.
Puéchal X; DeBandt M; Berthelot JM; Breban M; Dubost JJ; Fain O; Kahn JE; Lequen L; Longy-Boursier M; Perdriger A; Schaeverbeke T; Toussirot E; Sibilia J;
Arthritis Care Res (Hoboken); 2011 Jan; 63(1):155-9. PubMed ID: 20740616
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review.
Ortiz-Sanjuán F; Blanco R; Riancho-Zarrabeitia L; Castañeda S; Olivé A; Riveros A; Velloso-Feijoo ML; Narváez J; Jiménez-Moleón I; Maiz-Alonso O; Ordóñez C; Bernal JA; Hernández MV; Sifuentes-Giraldo WA; Gómez-Arango C; Galíndez-Agirregoikoa E; Blanco-Madrigal J; Ortiz-Santamaria V; Del Blanco-Barnusell J; De Dios JR; Moreno M; Fiter J; Riscos ML; Carreira P; Rodriguez-Valls MJ; González-Vela MC; Calvo-Río V; Loricera J; Palmou-Fontana N; Pina T; Llorca J; González-Gay MA
Medicine (Baltimore); 2015 Sep; 94(39):e1554. PubMed ID: 26426623
[TBL] [Abstract][Full Text] [Related]
10. Successful tocilizumab therapy in seven patients with refractory adult-onset Still's disease.
Bannai E; Yamashita H; Kaneko S; Ueda Y; Ozaki T; Tsuchiya H; Takahashi Y; Kaneko H; Kano T; Mimori A
Mod Rheumatol; 2016; 26(2):297-301. PubMed ID: 24697199
[TBL] [Abstract][Full Text] [Related]
11. Treatment of refractory adult onset Still's disease with tocilizumab-a single centre experience and literature review.
Reihl Crnogaj M; Čubelić D; Babić A; Mayer M; Anić B
Rheumatol Int; 2020 Aug; 40(8):1317-1325. PubMed ID: 32506202
[TBL] [Abstract][Full Text] [Related]
12. A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6.
Kadavath S; Zapantis E; Zolty R; Efthimiou P
Int J Rheum Dis; 2014 Mar; 17(3):336-40. PubMed ID: 24581387
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.
Sakai R; Nagasawa H; Nishi E; Okuyama A; Takei H; Kurasawa T; Kondo T; Nishimura K; Shirai Y; Ito T; Kameda H; Takeuchi T; Amano K
Clin Rheumatol; 2012 Mar; 31(3):569-74. PubMed ID: 22215118
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry.
Sota J; Vitale A; Lopalco G; Pereira RMR; Giordano HF; Antonelli IPB; Makowska J; Brzezińska O; Lewandowska-Polak A; Ruscitti P; Cipriani P; Cola ID; Govoni M; Ruffili F; Sfikakis PP; Laskari K; Ragab G; Hussein MA; Gentileschi S; Gaggiano C; La Torre F; Maier A; Emmi G; Marino A; Ciccia F; Sfriso P; Maggio MC; Bartoloni E; Lomater C; Hegazy MT; Tektonidou M; Dagostin MA; Opinc A; Sebastiani GD; Giacomelli R; Giudice ED; Olivieri AN; Tufan A; Kardas RK; Nuzzolese R; Cardinale F; Więsik-Szewczyk E; Veronica P; Tarsia M; Iannone F; Della Casa F; Fabiani C; Frediani B; Balistreri A; Rigante D; Cantarini L
Semin Arthritis Rheum; 2022 Dec; 57():152089. PubMed ID: 36063578
[TBL] [Abstract][Full Text] [Related]
15. Urticarial rash, fever, and arthritis: A case of refractory Adult-onset Still's disease with good response to tocilizumab.
Wawrzycki B; Krasowska D; Pietrzak A; Wielosz E; Majdan M; Lotti T
Dermatol Ther; 2019 Sep; 32(5):e13041. PubMed ID: 31361930
[TBL] [Abstract][Full Text] [Related]
16. Adult-onset still's disease and treatment results with tocilizumab.
Kır S; Özgen M; Zontul S
Int J Clin Pract; 2021 Mar; 75(3):e13936. PubMed ID: 33332679
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
Park EH; Lee EY; Shin K; Kim HA
Rheumatol Int; 2020 May; 40(5):791-798. PubMed ID: 31598752
[TBL] [Abstract][Full Text] [Related]
18. The effectiveness of tocilizumab in treating refractory adult-onset Still's disease with dichotomous phenotypes: IL-18 is a potential predictor of therapeutic response.
Tang KT; Hsieh CW; Chen HH; Chen YM; Chang SH; Huang PH; Lan JL; Chen DY
Clin Rheumatol; 2022 Feb; 41(2):557-566. PubMed ID: 34535869
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of biological agents in adult-onset Still's disease.
Cavalli G; Franchini S; Aiello P; Guglielmi B; Berti A; Campochiaro C; Sabbadini MG; Baldissera E; Dagna L
Scand J Rheumatol; 2015; 44(4):309-14. PubMed ID: 25656459
[TBL] [Abstract][Full Text] [Related]
20. Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab.
Imaizumi C; Saito M; Abe F; Kaga H; Saito A; Nara M; Kameyama S; Miura H; Ogasawara H; Hirakawa T; Mizunuma M; Satoh M; Komatsuda A; Terada Y; Takahashi N
Intern Med; 2022 Oct; 61(20):3137-3140. PubMed ID: 35283384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
